Literature DB >> 28182948

Zika Virus Pathogenesis and Tissue Tropism.

Jonathan J Miner1, Michael S Diamond2.   

Abstract

Although Zika virus (ZIKV) was isolated approximately 70 years ago, few experimental studies had been published prior to 2016. The recent spread of ZIKV to countries in the Western Hemisphere is associated with reports of microcephaly, congenital malformations, and Guillain-Barré syndrome. This has resulted in ZIKV being declared a public health emergency and has greatly accelerated the pace of ZIKV research and discovery. Within a short time period, useful mouse and non-human primate disease models have been established, and pre-clinical evaluation of therapeutics and vaccines has begun. Unexpectedly, ZIKV exhibits a broad tropism and persistence in body tissues and fluids, which contributes to the clinical manifestations and epidemiology that have been observed during the current epidemic. In this Review, we highlight recent advances in our understanding of ZIKV pathogenesis, tissue tropism, and the resulting pathology and discuss areas for future investigation.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Zika virus; congenital infection; flavivirus; host immunity; innate immunity; microcephaly; pathogenesis; tropism; viral persistence

Mesh:

Substances:

Year:  2017        PMID: 28182948      PMCID: PMC5328190          DOI: 10.1016/j.chom.2017.01.004

Source DB:  PubMed          Journal:  Cell Host Microbe        ISSN: 1931-3128            Impact factor:   21.023


  94 in total

1.  Zika virus. I. Isolations and serological specificity.

Authors:  G W A DICK; S F KITCHEN; A J HADDOW
Journal:  Trans R Soc Trop Med Hyg       Date:  1952-09       Impact factor: 2.184

2.  Zika Virus Targets Different Primary Human Placental Cells, Suggesting Two Routes for Vertical Transmission.

Authors:  Takako Tabata; Matthew Petitt; Henry Puerta-Guardo; Daniela Michlmayr; Chunling Wang; June Fang-Hoover; Eva Harris; Lenore Pereira
Journal:  Cell Host Microbe       Date:  2016-07-18       Impact factor: 21.023

3.  Protective efficacy of multiple vaccine platforms against Zika virus challenge in rhesus monkeys.

Authors:  Peter Abbink; Rafael A Larocca; Rafael A De La Barrera; Christine A Bricault; Edward T Moseley; Michael Boyd; Marinela Kirilova; Zhenfeng Li; David Ng'ang'a; Ovini Nanayakkara; Ramya Nityanandam; Noe B Mercado; Erica N Borducchi; Arshi Agarwal; Amanda L Brinkman; Crystal Cabral; Abishek Chandrashekar; Patricia B Giglio; David Jetton; Jessica Jimenez; Benjamin C Lee; Shanell Mojta; Katherine Molloy; Mayuri Shetty; George H Neubauer; Kathryn E Stephenson; Jean Pierre S Peron; Paolo M de A Zanotto; Johnathan Misamore; Brad Finneyfrock; Mark G Lewis; Galit Alter; Kayvon Modjarrad; Richard G Jarman; Kenneth H Eckels; Nelson L Michael; Stephen J Thomas; Dan H Barouch
Journal:  Science       Date:  2016-08-04       Impact factor: 47.728

4.  Guillain-Barré Syndrome outbreak associated with Zika virus infection in French Polynesia: a case-control study.

Authors:  Van-Mai Cao-Lormeau; Alexandre Blake; Sandrine Mons; Stéphane Lastère; Claudine Roche; Jessica Vanhomwegen; Timothée Dub; Laure Baudouin; Anita Teissier; Philippe Larre; Anne-Laure Vial; Christophe Decam; Valérie Choumet; Susan K Halstead; Hugh J Willison; Lucile Musset; Jean-Claude Manuguerra; Philippe Despres; Emmanuel Fournier; Henri-Pierre Mallet; Didier Musso; Arnaud Fontanet; Jean Neil; Frédéric Ghawché
Journal:  Lancet       Date:  2016-03-02       Impact factor: 79.321

5.  Expression Analysis Highlights AXL as a Candidate Zika Virus Entry Receptor in Neural Stem Cells.

Authors:  Tomasz J Nowakowski; Alex A Pollen; Elizabeth Di Lullo; Carmen Sandoval-Espinosa; Marina Bershteyn; Arnold R Kriegstein
Journal:  Cell Stem Cell       Date:  2016-03-30       Impact factor: 24.633

Review 6.  Flavivirus transmission focusing on Zika.

Authors:  Nikos Vasilakis; Scott C Weaver
Journal:  Curr Opin Virol       Date:  2016-12-06       Impact factor: 7.090

7.  Zika Virus Targets Human STAT2 to Inhibit Type I Interferon Signaling.

Authors:  Alesha Grant; Sanket S Ponia; Shashank Tripathi; Vinod Balasubramaniam; Lisa Miorin; Marion Sourisseau; Megan C Schwarz; Mari Paz Sánchez-Seco; Matthew J Evans; Sonja M Best; Adolfo García-Sastre
Journal:  Cell Host Microbe       Date:  2016-05-19       Impact factor: 21.023

8.  Zika Virus Is Not Uniquely Stable at Physiological Temperatures Compared to Other Flaviviruses.

Authors:  Leslie Goo; Kimberly A Dowd; Alexander R Y Smith; Rebecca S Pelc; Christina R DeMaso; Theodore C Pierson
Journal:  MBio       Date:  2016-09-06       Impact factor: 7.867

9.  Zika Virus Infection in Dexamethasone-immunosuppressed Mice Demonstrating Disseminated Infection with Multi-organ Involvement Including Orchitis Effectively Treated by Recombinant Type I Interferons.

Authors:  Jasper Fuk-Woo Chan; Anna Jinxia Zhang; Chris Chung-Sing Chan; Cyril Chik-Yan Yip; Winger Wing-Nga Mak; Houshun Zhu; Vincent Kwok-Man Poon; Kah-Meng Tee; Zheng Zhu; Jian-Piao Cai; Jessica Oi-Ling Tsang; Kenn Ka-Heng Chik; Feifei Yin; Kwok-Hung Chan; Kin-Hang Kok; Dong-Yan Jin; Rex Kwok-Him Au-Yeung; Kwok-Yung Yuen
Journal:  EBioMedicine       Date:  2016-11-12       Impact factor: 8.143

10.  Characterization of a Novel Murine Model to Study Zika Virus.

Authors:  Shannan L Rossi; Robert B Tesh; Sasha R Azar; Antonio E Muruato; Kathryn A Hanley; Albert J Auguste; Rose M Langsjoen; Slobodan Paessler; Nikos Vasilakis; Scott C Weaver
Journal:  Am J Trop Med Hyg       Date:  2016-03-28       Impact factor: 2.345

View more
  147 in total

1.  Vesicular Stomatitis Virus and DNA Vaccines Expressing Zika Virus Nonstructural Protein 1 Induce Substantial but Not Sterilizing Protection against Zika Virus Infection.

Authors:  Anzhong Li; Miaoge Xue; Zayed Attia; Jingyou Yu; Mijia Lu; Chao Shan; Xueya Liang; Thomas Z Gao; Pei-Yong Shi; Mark E Peeples; Prosper N Boyaka; Shan-Lu Liu; Jianrong Li
Journal:  J Virol       Date:  2020-08-17       Impact factor: 5.103

2.  Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody.

Authors:  Shannon R Esswein; Harry B Gristick; Andrea Jurado; Avery Peace; Jennifer R Keeffe; Yu E Lee; Alisa V Voll; Mohsan Saeed; Michel C Nussenzweig; Charles M Rice; Davide F Robbiani; Margaret R MacDonald; Pamela J Bjorkman
Journal:  Proc Natl Acad Sci U S A       Date:  2020-04-22       Impact factor: 11.205

3.  Femur-sparing pattern of abnormal fetal growth in pregnant women from New York City after maternal Zika virus infection.

Authors:  Christie L Walker; Audrey A Merriam; Eric O Ohuma; Manjiri K Dighe; Michael Gale; Lakshmi Rajagopal; Aris T Papageorghiou; Cynthia Gyamfi-Bannerman; Kristina M Adams Waldorf
Journal:  Am J Obstet Gynecol       Date:  2018-05-05       Impact factor: 8.661

4.  A Combination of Two Human Monoclonal Antibodies Prevents Zika Virus Escape Mutations in Non-human Primates.

Authors:  Jennifer R Keeffe; Koen K A Van Rompay; Priscilla C Olsen; Qiao Wang; Anna Gazumyan; Stephanie A Azzopardi; Dennis Schaefer-Babajew; Yu E Lee; Jackson B Stuart; Anil Singapuri; Jennifer Watanabe; Jodie Usachenko; Amir Ardeshir; Mohsan Saeed; Marianna Agudelo; Thomas Eisenreich; Stylianos Bournazos; Thiago Y Oliveira; Charles M Rice; Lark L Coffey; Margaret R MacDonald; Pamela J Bjorkman; Michel C Nussenzweig; Davide F Robbiani
Journal:  Cell Rep       Date:  2018-11-06       Impact factor: 9.423

5.  Recurrent Potent Human Neutralizing Antibodies to Zika Virus in Brazil and Mexico.

Authors:  Davide F Robbiani; Leonia Bozzacco; Jennifer R Keeffe; Ricardo Khouri; Priscilla C Olsen; Anna Gazumyan; Dennis Schaefer-Babajew; Santiago Avila-Rios; Lilian Nogueira; Roshni Patel; Stephanie A Azzopardi; Lion F K Uhl; Mohsan Saeed; Edgar E Sevilla-Reyes; Marianna Agudelo; Kai-Hui Yao; Jovana Golijanin; Harry B Gristick; Yu E Lee; Arlene Hurley; Marina Caskey; Joy Pai; Thiago Oliveira; Elsio A Wunder; Gielson Sacramento; Nivison Nery; Cibele Orge; Federico Costa; Mitermayer G Reis; Neena M Thomas; Thomas Eisenreich; Daniel M Weinberger; Antonio R P de Almeida; Anthony P West; Charles M Rice; Pamela J Bjorkman; Gustavo Reyes-Teran; Albert I Ko; Margaret R MacDonald; Michel C Nussenzweig
Journal:  Cell       Date:  2017-05-04       Impact factor: 41.582

Review 6.  The continued threat of emerging flaviviruses.

Authors:  Theodore C Pierson; Michael S Diamond
Journal:  Nat Microbiol       Date:  2020-05-04       Impact factor: 17.745

7.  IL-1 receptor antagonist therapy mitigates placental dysfunction and perinatal injury following Zika virus infection.

Authors:  Jun Lei; Meghan S Vermillion; Bei Jia; Han Xie; Li Xie; Michael W McLane; Jeanne S Sheffield; Andrew Pekosz; Amanda Brown; Sabra L Klein; Irina Burd
Journal:  JCI Insight       Date:  2019-02-28

8.  Zika virus elicits inflammation to evade antiviral response by cleaving cGAS via NS1-caspase-1 axis.

Authors:  Yanyan Zheng; Qingxiang Liu; Yaoxing Wu; Ling Ma; Zhenzhen Zhang; Tao Liu; Shouheng Jin; Yuanchu She; Yi-Ping Li; Jun Cui
Journal:  EMBO J       Date:  2018-07-31       Impact factor: 11.598

9.  Atlastin Endoplasmic Reticulum-Shaping Proteins Facilitate Zika Virus Replication.

Authors:  Blandine Monel; Maaran Michael Rajah; Mohamed Lamine Hafirassou; Samy Sid Ahmed; Julien Burlaud-Gaillard; Peng-Peng Zhu; Quentin Nevers; Julian Buchrieser; Françoise Porrot; Cécile Meunier; Sonia Amraoui; Maxime Chazal; Audrey Salles; Nolwenn Jouvenet; Philippe Roingeard; Craig Blackstone; Ali Amara; Olivier Schwartz
Journal:  J Virol       Date:  2019-11-13       Impact factor: 5.103

10.  Chromosome 19 microRNAs exert antiviral activity independent from type III interferon signaling.

Authors:  Avraham Bayer; Nicholas J Lennemann; Yingshi Ouyang; Elena Sadovsky; Megan A Sheridan; R Michael Roberts; Carolyn B Coyne; Yoel Sadovsky
Journal:  Placenta       Date:  2017-11-10       Impact factor: 3.481

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.